Nuveen Asset Management, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 88 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 7.52 and the average weighting 0.6%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$16,721,776
-12.3%
1,314,605
-3.0%
0.01%
-14.3%
Q2 2023$19,072,275
+93345.7%
1,354,565
+2.5%
0.01%
-12.5%
Q1 2023$20,410
+43.0%
1,321,016
+51.8%
0.01%
+33.3%
Q4 2022$14,268
-99.9%
870,500
+7.0%
0.01%0.0%
Q3 2022$15,052,000
+190.7%
813,649
+465.8%
0.01%
+200.0%
Q2 2022$5,177,000
+13.5%
143,798
+13.4%
0.00%
+100.0%
Q1 2022$4,563,000
+1.2%
126,753
+1.2%
0.00%0.0%
Q4 2021$4,508,000
-5.5%
125,217
-13.5%
0.00%0.0%
Q3 2021$4,772,000
+57.4%
144,679
-4.8%
0.00%0.0%
Q2 2021$3,032,000
-5.9%
151,957
-5.9%
0.00%0.0%
Q1 2021$3,223,000
-10.9%
161,564
-10.9%
0.00%0.0%
Q4 2020$3,619,000
-0.2%
181,390
-0.2%
0.00%0.0%
Q3 2020$3,626,000
-0.4%
181,793
-0.3%
0.00%0.0%
Q2 2020$3,639,000
-16.1%
182,420
+73.2%
0.00%
-50.0%
Q1 2020$4,336,000
-58.1%
105,317
-36.6%
0.00%
-50.0%
Q4 2019$10,342,000
+0.8%
166,157
-45.0%
0.00%0.0%
Q3 2019$10,259,000
+815.2%
302,261
+508.1%
0.00%
Q2 2019$1,121,00049,7080.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 4,104,140$93,041,00043.52%
SV Health Investors, LLC 1,716,303$38,909,00020.55%
PURA VIDA INVESTMENTS, LLC 68,154$1,545,0000.65%
Redmile Group, LLC 683,880$14,658,0000.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 77,000$1,746,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 224,154$5,008,0000.59%
EMERALD ADVISERS, LLC 482,626$10,941,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 416,342$9,438,0000.38%
Orbimed Advisors 1,176,070$26,662,0000.34%
VIKING GLOBAL INVESTORS LP 2,394,625$54,286,0000.33%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders